Neurim has been allowed to continue its case in the UK, in which it is seeking an injunction against Defendant Myla… https://t.co/1pmIv96OND

We held the second event in our Healthcare Innovation & Strategy Series earlier this week. Here’s a recap! Our spea… https://t.co/lMEKc9JhbT